Fig. 3From: Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regressionEffect of non-statin lipid-lowering therapy on total atheroma volume. Global and subgroup drug analysis. Random effects, mean difference, 95% confidence intervals (CI) and I2 statistics. TAV: total atheroma volume; Dif: differenceBack to article page